Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy

BACKGROUND: Immunotherapy of cancer is successful but tumor regression often is incomplete and followed by escape. Understanding the mechanisms underlying this acquired resistance will aid the development of more effective treatments. METHODS: We exploited a mouse model where tumor-specific therapeu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Beyranvand Nejad, Elham, Labrie, Camilla, Abdulrahman, Ziena, van Elsas, Marit J, Rademaker, Eva, Kleinovink, Jan Willem, van der Sluis, Tetje C, van Duikeren, Suzanne, Teunisse, Amina F A.S, Jochemsen, Aart G, Oosting, Jan, de Miranda, Noel F C C, Van Hall, Thorbald, Arens, Ramon, van der Burg, Sjoerd H
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Basic Tumor Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7467529/
https://ncbi.nlm.nih.gov/pubmed/32873723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001326
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados